
David Guzo
Examiner (ID: 9040)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1805, 2899 |
| Total Applications | 1205 |
| Issued Applications | 693 |
| Pending Applications | 160 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6750435
[patent_doc_number] => 20030044955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same'
[patent_app_type] => new
[patent_app_number] => 10/105481
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15588
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044955.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105481
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105481 | Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same | Mar 19, 2002 | Abandoned |
Array
(
[id] => 6774259
[patent_doc_number] => 20030017597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Hybrid vectors for gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/102610
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8863
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102610
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102610 | Hybrid vectors for gene therapy | Mar 18, 2002 | Issued |
Array
(
[id] => 6720859
[patent_doc_number] => 20030054548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Lentiviral packaging constructs'
[patent_app_type] => new
[patent_app_number] => 10/097002
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9212
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054548.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097002
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097002 | Lentiviral packaging constructs | Mar 12, 2002 | Issued |
| 90/006245 | VESICULAR COMPLEXES AND METHODS OF MAKING AND USING THE SAME | Mar 11, 2002 | Issued |
Array
(
[id] => 6808657
[patent_doc_number] => 20030198596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Isolation of a gene encoding human thyrotropin beta subunit'
[patent_app_type] => new
[patent_app_number] => 10/091706
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1797
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20030198596.pdf
[firstpage_image] =>[orig_patent_app_number] => 10091706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/091706 | Isolation of a gene encoding human thyrotropin beta subunit | Mar 4, 2002 | Abandoned |
Array
(
[id] => 314525
[patent_doc_number] => 07524493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension'
[patent_app_type] => utility
[patent_app_number] => 10/468404
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 45
[patent_no_of_words] => 13445
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524493.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468404
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468404 | Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension | Feb 27, 2002 | Issued |
Array
(
[id] => 654510
[patent_doc_number] => 07109029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Vector constructs'
[patent_app_type] => utility
[patent_app_number] => 10/081961
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 8
[patent_no_of_words] => 8579
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109029.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081961
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081961 | Vector constructs | Feb 21, 2002 | Issued |
Array
(
[id] => 6715991
[patent_doc_number] => 20030027339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Micellar systems'
[patent_app_type] => new
[patent_app_number] => 10/081461
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15666
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027339.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081461
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081461 | Micellar systems | Feb 20, 2002 | Issued |
Array
(
[id] => 5786292
[patent_doc_number] => 20020159979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Adeno-associated virus materials and methods'
[patent_app_type] => new
[patent_app_number] => 10/077294
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7090
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20020159979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077294
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077294 | Adeno-associated virus materials and methods | Feb 14, 2002 | Abandoned |
Array
(
[id] => 6720865
[patent_doc_number] => 20030054554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Albumin derivatives with therapeutic functions'
[patent_app_type] => new
[patent_app_number] => 10/073118
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 15773
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10073118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/073118 | Albumin derivatives with therapeutic functions | Feb 11, 2002 | Abandoned |
Array
(
[id] => 6720863
[patent_doc_number] => 20030054552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Recombinational cloning using engineered recombination sites'
[patent_app_type] => new
[patent_app_number] => 10/058292
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 16561
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10058292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/058292 | Recombinational cloning using engineered recombination sites | Jan 29, 2002 | Issued |
Array
(
[id] => 746005
[patent_doc_number] => 07026527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-11
[patent_title] => 'Plant methionine synthase gene and methods for increasing the methionine content of the seeds of plants'
[patent_app_type] => utility
[patent_app_number] => 09/989339
[patent_app_country] => US
[patent_app_date] => 2002-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 2
[patent_no_of_words] => 25000
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026527.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989339
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989339 | Plant methionine synthase gene and methods for increasing the methionine content of the seeds of plants | Jan 27, 2002 | Issued |
Array
(
[id] => 1012574
[patent_doc_number] => 06897045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-24
[patent_title] => 'Adeno-associated virus vectors'
[patent_app_type] => utility
[patent_app_number] => 10/054665
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 56
[patent_no_of_words] => 29267
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/897/06897045.pdf
[firstpage_image] =>[orig_patent_app_number] => 10054665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/054665 | Adeno-associated virus vectors | Jan 21, 2002 | Issued |
Array
(
[id] => 5631579
[patent_doc_number] => 20060148049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Gene disrupted yeast'
[patent_app_type] => utility
[patent_app_number] => 10/250297
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9237
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250297 | Gene disrupted yeast | Jan 17, 2002 | Abandoned |
Array
(
[id] => 7243097
[patent_doc_number] => 20050257287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Vectors capable of imparting herbicide resistance and viral cross protection and methods'
[patent_app_type] => utility
[patent_app_number] => 10/466794
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7188
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20050257287.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466794
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466794 | Vectors capable of imparting herbicide resistance and viral cross protection and methods | Jan 17, 2002 | Abandoned |
Array
(
[id] => 1100869
[patent_doc_number] => 06814963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-09
[patent_title] => 'Baculovirus-based expression system'
[patent_app_type] => B2
[patent_app_number] => 10/050665
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6354
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/814/06814963.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050665 | Baculovirus-based expression system | Jan 15, 2002 | Issued |
Array
(
[id] => 1009111
[patent_doc_number] => 06899871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => 'Gene delivery system and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/043912
[patent_app_country] => US
[patent_app_date] => 2002-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 37
[patent_no_of_words] => 18574
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/899/06899871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10043912
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/043912 | Gene delivery system and methods of use | Jan 10, 2002 | Issued |
Array
(
[id] => 570236
[patent_doc_number] => 07459153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-02
[patent_title] => 'Viral vectors for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/250304
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10207
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/459/07459153.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250304 | Viral vectors for gene therapy | Jan 3, 2002 | Issued |
Array
(
[id] => 699244
[patent_doc_number] => 07067497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Modulation of telomere length by oligonucleotides having a G-core sequence'
[patent_app_type] => utility
[patent_app_number] => 10/038335
[patent_app_country] => US
[patent_app_date] => 2002-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6702
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038335 | Modulation of telomere length by oligonucleotides having a G-core sequence | Jan 1, 2002 | Issued |
Array
(
[id] => 1144242
[patent_doc_number] => 06773702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-10
[patent_title] => 'Use of combretastatin A4 and its prodrugs as an immune enhancing therapy'
[patent_app_type] => B2
[patent_app_number] => 10/034746
[patent_app_country] => US
[patent_app_date] => 2001-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 10574
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/773/06773702.pdf
[firstpage_image] =>[orig_patent_app_number] => 10034746
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/034746 | Use of combretastatin A4 and its prodrugs as an immune enhancing therapy | Dec 25, 2001 | Issued |